Skip Navigation Links
Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
   Division of Sexually Transmitted Diseases
    Program and Training Branch
STD Prevention STD Training Home Links Contact Us Glossary 
STD Prevention
Self-Study Modules
Herpes Simplex Virus (HSV)
Course Objective
Line separator
Target audience
Line separator
Continuing education
Lessons
Line separator
Epidemiology
Line separator
Pathogenesis and microbiology
Line separator
Clinical manifestations and sequelae
Line separator
Diagnostic methods
Line separator
Patient management / treatment
Line separator
Patient counseling and education
Line separator
Partner management / Public health
Line separator
Case study
Line separator
Resources
Line separator
 
 
 

Self-Study STD Module - Human Papilloma Virus (HPV)

Resources

Publications

  1. American Cancer Society. Cancer facts and figures 2003. Available from URL: http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf.
  2. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Kornegay JR, et al. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003; 187(7):1064-1070.
  3. Beutner KR, et al. External Genital Warts: Report of the American Medical Association Consensus Conference. Clin Inf Dis 1998;27:796-806
  4. Burk RD, et al. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 1996; 174:679-689.
  5. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. NEJM 2002; 346(15):1105-1112.
  6. Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002; 89(2):191-199.
  7. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. JNCI Monographs 2003;(31):20-28.
  8. Castle PE, Giuliano AR. Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients--assessing their roles as human papillomavirus cofactors. JNCI Monographs 2003;(31):29-34.
  9. Cates W, American Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 1999; 26(suppl):52-57.
  10. CDC. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002;51 (No. RR-6). Available from URL: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5106a1.htm.
  11. CDC. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 1999; 48:1-87. Available from URL: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4810a1.htm.
  12. CDC. Prevention of genital HPV infection and sequelae: report of an external consultants' meeting, 1999:1-33. Available from URL: http://www.cdc.gov/nchstp/dstd/Reports_Publications/99HPVReport.htm.
  13. Chang F, Syrjanen S, Kellokoski J, Syrjanen K. Human papillomavirus (HPV) infections and their associations with oral disease. J Oral Pathol Med 1991; 20(7):305-317.
  14. Eddy DM. Screening for cervical cancer. Ann Int Med 1990; 113(3):214-226.
  15. Fairley CK, Chen S, Tabrizi SN, McNeil J, Becker G, Walker R, et al. Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment. Nephrology Dialysis Transplantation 1994; 9(4):416-420.
  16. Ferenczy A, Bergeron C, Richart RM. Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections. Obstet Gynecol 1989; 74(6):950-954.
  17. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180(5):1415-1423.
  18. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169(2):235-240.
  19. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001; 84(9):1219-1226.
  20. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RDl. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338(7):423-428.
  21. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. JNCI 1995; 87(18):1365-1371.
  22. Hogewoning CJ, Bleeker MC, Van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003; 107; 811-816.
  23. Holmes KK, Mardh PA, Sparling PF, Weisner PJ, eds. Sexually Transmitted Diseases, third edition. Chapters 24, 25, 59, 86. New York: McGraw-Hill, Inc., 1999.
  24. Jamieson DJ, Duerr A, Burk R, Klein RS, Paramsothy P, Schuman P, et al. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol 2002; 186(1):21-27.
  25. Jenkins D. Diagnosing human papillomaviruses: recent advances. Curr Opin Infect Dis 2001; 14:53-56.
  26. Karlsson R, Jonsson M, Edlund K, Evander M, Gustavsson A, Boden E, et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 1995; 22(2):119-127.
  27. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine.[comment]. NEJM 2002; 347(21):1645-1651.
  28. Koutsky LA. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102(5A):3-8.
  29. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiologic Reviews 1988; 10:122-163.
  30. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29(11):725-735.
  31. Manos MM, et al. Identifying women with cervical neoplasia. JAMA 1999; 281(17):1605-1610.
  32. Molano M, Van den BA, Plummer M, Weiderpass E, Posso H, Arslan A, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol 2003; 158(5):486-494.
  33. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.[comment]. JAMA 2001; 285(23):2995-3002.
  34. Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 2000; 154(2):127-134.
  35. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132(2):277-284.
  36. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19(1-2):1-5.
  37. Munoz N, Bosch FX. Epidemiology of cervical cancer. IARC Scientific Publications 1989;(94):9-39.
  38. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000; 151(12):1158-1171.
  39. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12:186-92
  40. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183(11):1554-1564.
  41. Roden RB, Lowy DR, Schiller JT. Papillomavirus is resistant to desiccation. J Infect Dis 1997; 176(4):1076-1079.
  42. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. JNCI Monographs 2003;(31):14-19.
  43. Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. JNCI 2003; 95(17):1336-1343.
  44. Sedjo RL, Fowler BM, Schneider A, Henning SM, Hatch K, Giuliano AR. Folate, vitamin B12, and homocysteine status. findings of no relation between human papillomavirus persistence and cervical dysplasia. Nutrition 2003; 19(6):497-502.
  45. Sith JS, Green J, Berrington G, Appleby P, Peto J, Plummer M, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003; 361(9364):1159-1167.
  46. Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002; 185(3):324-331.
  47. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. JNCI 2001; 93:293-299.
  48. Svare EI, et al. Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence. Int J Cancer 1998; 75:1-8.
  49. U.S. Preventive Services Task Force. Screening for Cervical Cancer. AHRQ Publication No. 03-515A, 2003. Rockville (MD): Agency for Healthcare Research and Quality. Available from URL: http://www.ahrq.gov/clinic/3rduspstf/cervcan/cervcanrr.htm#contents.
  50. von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000; 76:162-168.
  51. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Persp Sex Reprod Health 2004; 36(1): 6-10.
  52. Wright TC, Cox JT, Massad LS, et al. 2001 Consensus guidelines for management of women with cervical cytological abnormalities. JAMA 2002; 287(16): 2114-2129.
  53. Solomon D, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287(16):2114-2119.

Websites and Other Resources

 
 
 
Page 14 of 15 BackStatusStatusNext

 


STD Home | STD Index

CDC Home | Search | Health Topics A-Z

Centers for Disease Control and Prevention
 National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
     Division of Sexually Transmitted Diseases Prevention